Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1920
    Keywords: Arteriovenous malformations ; Embolisation ; Guide wire ; Minicatheter ; Progressive suppleness pursil catheter ; Superselective catheterisation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract For safe, more definitive embolisation of arteriovenous malformations, improved selectivity of the catheter is desirable. This report describes the advantage of the combined use of a progressive suppleness pursil catheter and a hydrophilic polymer-coated guide wire, together with precaution against complications. In 14 patients, 27 vessels were catheterised with this. Chemical embolisation using oestrogen alcohol and polyvinyl acetate was carried out only if sufficiencytly superselective catheterization was achieved with negative results on a provocation test. Chemical embolisation was successful in 25 vessels, but in three vessels catheterised very distally, it required much more time to withdraw the catheter because of the friction between it and the wall of the vessel.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1335
    Keywords: Boron neutron-capture therapy (BNCT) ; Anti-AFP monoclonal antibody ; Boron-10 ; Prompt-γ-ray spectrometry ; Thermal neutron
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract We described previously that10B atoms delivered by monoclonal antibody (mAb) exerted a cytotoxic effect on AH66 cells in a dose-dependent manner upon thermal neutron irradiationin vitro. In the present study, the delivering capacity of boronated anti-(α-fetoprotein) (AFP) mAb to carry10B atoms to AFP-producing tumor xenografts in nude mice was determined. Boronated mAb was prepared by conjugating 50 mM 10B compound to an anti-AFP mAb (2 mg/ml) usingN-succinimidyl-3-) (2-pyridyldithio) propionate. The number of10B atoms conjugated directly to the mAb was estimated to be 459/antibody by prompt γ-ray spectrometry. Boron concentrations in tumor tissue obtained 12, 24, 72, and 120 h after injection of 3.0 mg10B-conjugated anti-AFP mAb were 11.10±3.12 (SD,n=6), 29.30±5.11, 33.02±11.8, and 12.91±5.62 ppm respectively. For control10B-conjugated anti-dinitrophenol (DNP) mAb, the values were 9.59±0.99, 10.37±2.86, 10.00±2.95, and 8.83±4.71 ppm respectively. The concentrations in blood were less than 0.40±0.10 ppm with anti-AFP mAb and less than 0.51±0.15 ppm with anti-DNP mAb at each sampling time (12, 24, 72, and 120 h). The number of10B atoms delivered to the tumor cells was calculated to be 0.62×109, 1.63×109, 1.84×109 and 0.72×109 at each sampling time after injection of10B-anti-AFP mAb. The amount of10B atoms necessary for effective boron neutron-capture therapy was estimated to be 109/tumor cell. We were able to carry 1.84×109 10B atoms to AH66 tumor cells by using10B-anti-AFP mAb. The accumulation reached its peak 72 h after injection. These data indicated that the10B-conjugated antitumor mAb could deliver a sufficient amount of10B atoms to the tumor cells to induce cytotoxic effects 72 h after injection upon thermal neutron irradiation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...